Lv37
320 积分 2024-09-11 加入
Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis
18天前
已关闭
Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis
18天前
已关闭
Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages
23天前
已完结
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study
24天前
已完结
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
1个月前
已完结
Primary overall survival analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel versus standard-of-care therapy in relapsed/refractory large B-cell lymphoma
1个月前
已关闭
皖公网安备34019202002308
